These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 23437443

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation.
    Hall A, Simpson RFG, Mitchell ARJ.
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(1):58-63. PubMed ID: 28056733
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy.
    Zardavas D, Suter TM, Van Veldhuisen DJ, Steinseifer J, Noe J, Lauer S, Al-Sakaff N, Piccart-Gebhart MJ, de Azambuja E.
    J Clin Oncol; 2017 Mar 10; 35(8):878-884. PubMed ID: 28199174
    [Abstract] [Full Text] [Related]

  • 25. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage.
    Luani B, Rauwolf T, Groscheck T, Tanev I, Herold J, Isermann B, Schmeisser A, Braun-Dullaeus RC.
    Heart Lung Circ; 2018 Jul 10; 27(7):828-834. PubMed ID: 28818408
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.
    Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, Eikelboom J, Themeles E, Ezekowitz M, Wallentin L, Yusuf S, RE-LY Investigators.
    Circulation; 2013 Nov 12; 128(20):2192-201. PubMed ID: 24016454
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical Applications of Biomarkers in Atrial Fibrillation.
    Chang KW, Hsu JC, Toomu A, Fox S, Maisel AS.
    Am J Med; 2017 Dec 12; 130(12):1351-1357. PubMed ID: 28822701
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Diagnostic and prognostic importance of natriuretic peptide type B in patients with persistent atrial fibrillation - unfulfilled hopes].
    Musiał WJ.
    Kardiol Pol; 2010 Jul 12; 68(7):787-8. PubMed ID: 20648437
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke.
    Rodríguez-Yáñez M, Arias-Rivas S, Santamaría-Cadavid M, Sobrino T, Castillo J, Blanco M.
    Neurology; 2013 Jul 30; 81(5):444-7. PubMed ID: 23803318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.